Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Entecavir Add-on to PEG-IFN in Chronic Hepatitis B
NCT02368288Phase 4Unknown
- Sponsor
- Beijing Ditan Hospital
- Start
- Jan 2013
- Primary completion
- Dec 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of entecavir in Chronic Hepatitis B (CHB), sponsored by Beijing Ditan Hospital. Status: unknown.
02
Drugs
entecavir
03
Conditions
Chronic Hepatitis B (CHB)
Beyond the preview
Go deeper on NCT02368288.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02368288.